Michael A. Martino files SEC Form 4 disclosures for ONCOGENEX PHARMACEUTICALS, INC.. They have made 5 open-market trades across 2 companies since 2010, most recently 2023-05-24.
CIK 0001238250
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $22K since 2023, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMPE | BUY | 2023-05-24 | 2023-05-26 | $0.29 | $22K | -7.0% | -20.7% | -32.9% |
| OGXI | SELL | 2010-07-06 | 2010-07-08 | $13.02 | $33K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2010-06-03 | 2010-06-07 | $14.46 | $202K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2010-05-18 | 2010-05-20 | $18.18 | $27K | -34.8% | +1.7% | +1.7% |
| OGXI | SELL | 2010-05-13 | 2010-05-18 | $18.67 | $244K | -34.8% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.